Osteoporosis | Unmet Need | US/EU | 2016

Publish date: August 2016

Login to access report


Given the safety and tolerability profiles associated with current osteoporosis therapies, as well as the low drug-treatment and compliance rates, significant unmet need remains in the field of osteoporosis. A number of novel osteoporosis therapies are set to launch over the next five years, and it is anticipated that they may at least partially address current unmet needs.